NovaBay Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
NovaBay Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • NovaBay Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 4.89M shares, a 25.2% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 4.89M -1.64M -25.2% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 1.35M -2.87M -68% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 32M +30M +1474% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 321K -1.71M -84.2% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 6.53M -58.5M -90% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 4.21M -49.3M -92.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 2.04M -49.4M -96% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 2.04M +670K +49.1% Dec 31, 2022 10-K 2024-03-26
Q3 2022 65M +20M +44.6% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 53.5M +8.9M +19.9% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 51.4M +9.64M +23.1% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 1.37M -40.4M -96.7% Dec 31, 2021 10-K 2023-03-31
Q3 2021 44.9M +3.18M +7.62% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 44.6M +9.97M +28.8% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 41.8M +13.5M +48% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 41.8M +13.8M +49.6% Dec 31, 2020 10-K 2022-03-29
Q3 2020 41.8M +16.6M +65.7% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 34.6M +13.9M +67.1% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 28.2M +11.1M +65.2% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 27.9M +10.8M +63.5% Dec 31, 2019 10-K 2021-03-25
Q3 2019 25.2M +8.11M +47.5% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 20.7M +3.64M +21.3% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 17.1M +6K +0.04% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 17.1M +1.7M +11.1% Dec 31, 2018 10-K 2020-03-26
Q3 2018 17.1M +1.73M +11.2% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 17.1M +1.78M +11.6% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 17.1M +1.8M +11.8% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 15.4M +116K +0.76% Dec 31, 2017 10-K 2019-03-29
Q3 2017 15.4M -14.9B Sep 30, 2017 10-Q 2017-11-14
Q2 2017 15.3M +6.15M +67.2% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 15.3M +15.3M Mar 31, 2017 10-Q 2017-05-11
Q4 2016 15.3M +11.8M +338% Dec 31, 2016 10-K 2018-03-21
Q3 2016 14.9B* +14.8B Sep 30, 2016 10-Q 2016-11-10
Q2 2016 9.16M -64.5M -87.6% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 5.08K* -61.1M Mar 31, 2016 10-Q 2016-05-12
Q4 2015 3.49M +1.42M +68.7% Dec 31, 2015 10-K 2017-03-23
Q3 2015 74.6M +23.5M +45.9% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 73.6M +22.9M +45% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 61.1M +10.4M +20.5% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 2.07M -42.6M -95.4% Dec 31, 2014 10-K 2016-03-04
Q3 2014 51.1M +12.5M +32.3% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 50.8M +13.4M +35.9% Jun 30, 2014 10-Q 2014-07-31
Q1 2014 50.7M +13.5M +36.2% Mar 31, 2014 10-Q 2014-05-01
Q4 2013 44.6M +7.71M +20.9% Dec 31, 2013 10-K 2015-03-26
Q3 2013 38.7M +8.9M +29.9% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 37.4M +8.49M +29.4% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 37.2M +8.41M +29.2% Mar 31, 2013 10-Q 2013-05-02
Q4 2012 36.9M +8.33M +29.1% Dec 31, 2012 10-K 2014-03-06
Q3 2012 29.7M +1.42M +4.99% Sep 30, 2012 10-Q 2012-11-01
Q2 2012 28.9M +5.38M +22.9% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 28.8M Mar 31, 2012 10-Q 2012-05-03
Q4 2011 28.6M +5.2M +22.2% Dec 31, 2011 10-K 2013-03-14
Q3 2011 28.3M Sep 30, 2011 10-Q 2011-11-07
Q2 2011 23.5M Jun 30, 2011 10-Q 2011-08-10
Q4 2010 23.4M Dec 31, 2010 10-K 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.